Final results of Suominen Corporation’s oversubscribed rights issue

Suominen’s rights issue was oversubscribed with 81,504,500 subscriptions for new shares (about 105.7% of the 77,121,272 offered). At EUR 0.36 per share, the company will raise gross proceeds of ~EUR 28 million and issue 77,121,272 new shares, increasing total shares from 58,259,219 to 135,380,491. Trading timelines were set for interim shares (on/around 3 July 2026) and new shares commencing (on/around 6 July 2026).

Analysis

This is more a balance-sheet repair than a growth signal. The key market mechanism is dilution: with the share count expanding by more than half, existing holders need a meaningful step-up in operating profit just to keep per-share economics flat, so the equity can still rerate down even if insolvency risk falls. The oversubscription matters mainly because it removes a forced-financing overhang and suggests creditors/customers are less likely to price a near-term distress event.

The first-order winner is the capital structure, not necessarily the common stock. Suppliers and customers benefit from lower counterparty risk, while competing nonwovens producers can lose less than one might expect because the raise likely stabilizes Suominen’s ability to compete on price and service rather than triggering share loss. The real second-order effect is on future negotiating power: a cleaner runway can let management push longer-dated contracts, but only if margins stop leaking.

Near term, the setup is technically fragile around the first post-merger trading sessions as interim-share conversion often creates supply. Over 1-3 months, the falsifier is simple: if management does not pair this with margin guidance improvement or a visible working-capital inflection, the market will treat the raise as an expensive delay, not a turnaround. Over 6-18 months, the thesis only works if incremental equity is followed by sustained free-cash-flow generation; otherwise dilution will be remembered as a stopgap that protected creditors more than shareholders.

Key Decisions for Investors

• Short/underweight SUY1V on any post-listing strength in the first 1-2 weeks after July 6; the risk/reward favors fading a technical bounce because dilution is already locked in. Cover if management raises FY26 EBITDA/FCF guidance or if the stock holds above the ex-rights adjusted level for two consecutive weeks on above-average volume.
• If options/liquidity are available, buy a 1-3 month put spread on SUY1V to express the dilution overhang with defined risk; target a 2:1 payoff if the market re-prices the company as a recap, not a recovery. Invalidated by a clear margin inflection in the next quarterly update.
• Stay out of any long equity until there is evidence the new capital is translating into lower net leverage and working-capital normalization, not just runway extension. This is a watch item for Q3 results, not an immediate turnaround long.
• Do not extrapolate this into a broad positive read-through for the named tickers in the data feed; the signal is idiosyncratic and liquidity-related rather than a sector-wide capital-return event.